Adverse event reporting of the IGF-1R monoclonal antibody teprotumumab: a real-world study based on the US food and drug administration adverse event reporting system
Article in Frontiers in Pharmacology (August 2024)
The most recent citing publications are shown below. View all 4 publications that cite this research output on Dimensions.
Article in Frontiers in Pharmacology (August 2024)
Article in Expert Opinion on Drug Safety (July 2024)
Article in Frontiers in Pharmacology (June 2024)